Version history
AntiCoagAF
40
ASO score
Text
51/100
Reviews
0/100
Graphic
60/100
Other
0/100
App Rating
5
Votes
1
App Age
12y 1m
Last Update
Mar 31, 2025
Compare with Category Top Apps
|
Metrics
|
Current App
|
Category Top Average
|
Difference
|
|---|---|---|---|
|
Rating
|
5
|
4.57
|
+9%
|
|
Number of Ratings (Voted)
|
1
|
65.1K
|
-100%
|
|
App Age
|
12y 0m
|
9y 5m
|
+28%
|
|
Price
|
$2
|
$2
|
+21%
|
|
In-app Purchases Price
|
$0
|
$35
|
|
|
Update Frequency
|
264d
|
141d
|
+88%
|
|
Title Length
|
10
|
25
|
-60%
|
|
Subtitle Length
|
27
|
26
|
+4%
|
|
Description Length
|
1 207
|
2 655
|
-55%
|
|
Number of Screenshots
|
1950
|
1375
|
+42
%
|
|
Size
|
5MB
|
277MB
|
-98
%
|
Category Ranking in United States
7 days
Last 7 days
Last 30 days
Last 90 days
Last 180 days
Last year
| Top | Dec 13, 2025 | Dec 20, 2025 |
|---|---|---|
|
No results were found!
|
||
| Top | Dec 13, 2025 | Dec 20, 2025 |
|---|---|---|
|
No results were found!
|
||
| Top | Dec 13, 2025 | Dec 20, 2025 |
|---|---|---|
|
No results were found!
|
||
| Top | Dec 13, 2025 | Dec 20, 2025 |
|---|---|---|
|
No results were found!
|
||
Ranking Keywords in United States
| Keywords | App Rank |
|---|
Analyze this and other apps using Asolytics tools
Text ASO
Title
(
Characters:
10
of 30
)
AntiCoagAF
Subtitle
(
Characters:
27
of 30
)
DOAC use in non-valvular AF
Description
(
Characters:
1207
of 4000
)
This application is for medical practitioners who need to quickly review which anticoagulant (including the direct oral anticoagulants (DOACs)) to use to prevent stroke in patients with non-valvular atrial fibrillation (NVAF).
It contains relevant information about warfarin, apixaban, dabigatran, rivaroxaban and edoxaban.
Topics covered include: comparison of anticoagulants, patient information, when anticoagulation is required, risk-benefit issues, when warfarin is appropriate, how to choose the dose of a DOAC, starting or switching between anticoagulants, edoxban information, clinical monitoring, bleeding risks, use of antiplatelet agents in addition to oral anticoagulants, managing ischemic strokes on DOACs, reversing anticoagulation in the event of intracerebral haemorrhage, a Cookcroft-Gault creatinine clearance calculator and peri-operative management information.
Information contained within the application was edited by Dr Bruce Campbell. Coding was by CereScape (www.cerescape.com). It is our aim to keep this information current, and we welcome constructive comments and evidenced updated information. Any profit generated by this application will be used to fund stroke research.}
Read more
Other
Additional Information
Version history
1.3.2
Mar 31, 2025
Miscellaneous bug fixes and updated for iOS 16+.
1.3
Feb 02, 2022
Updated by Prof Bruce Campbell, University of Melbourne, for 2022 use. Added information about new DOAC reversal agents. Helpful for management of stroke, peri-operative care and other decisions involving DOAC use.